UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 426

Sortiert nach

JAK/STAT signaling in hematological malignancies

Oncogene, 2013-05, Vol.32 (21), p.2601-2613

2013

Volltextzugriff (PDF)

The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases

Leukemia, 2014-03, Vol.28 (3), p.485-496

2014

Volltextzugriff (PDF)

MPL/JAK2: from one signaling pathway to several disorders

Leukemia research, 2016-05, Vol.44, p.S2-S2

Vainchenker, W

2016

Volltextzugriff (PDF)

JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma

Leukemia, 2014-02, Vol.28 (2), p.338-348

2014

Volltextzugriff (PDF)

Thrombopoietin receptor is required for the oncogenic function of CALR mutants

Leukemia, 2016-08, Vol.30 (8), p.1759-1763

2016

Volltextzugriff (PDF)

Mutations of ASXL1 gene in myeloproliferative neoplasms

Leukemia, 2009-11, Vol.23 (11), p.2183-2186

2009

Volltextzugriff (PDF)

Pathologic activation of thrombopoietin receptor and JAK2-STAT5 pathway by frameshift mutants of mouse calreticulin

Leukemia, 2016-08, Vol.30 (8), p.1775-1778

2016

Volltextzugriff (PDF)

A role for reactive oxygen species in JAK2 V617F myeloproliferative neoplasm progression

Leukemia, 2013-11, Vol.27 (11), p.2187-2195

2013

Volltextzugriff (PDF)

JAK2 negatively regulates p53 stabilization by enhancing MDM2 via La expression in myeloproliferative neoplasms

Oncogene, 2012-03, Vol.31 (10), p.1323-1333

2012

Volltextzugriff (PDF)

From hematopoietic stem cells to platelets

Journal of thrombosis and haemostasis, 2007-07, Vol.5 (s1), p.318-327

2007

Volltextzugriff (PDF)

Myelofibrosis, JAK2 inhibitors and erythropoiesis

Leukemia, 2013-06, Vol.27 (6), p.1219-1223

2013

Volltextzugriff (PDF)

The cell division control protein 42–Src family kinase–neural Wiskott–Aldrich syndrome protein pathway regulates human proplatelet formation

Journal of thrombosis and haemostasis, 2016-12, Vol.14 (12), p.2524-2535

2016

Volltextzugriff (PDF)

TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis

Leukemia, 2009-05, Vol.23 (5), p.905-911

2009

Volltextzugriff (PDF)

Regulation of megakaryocyte maturation and platelet formation

Journal of thrombosis and haemostasis, 2009-07, Vol.7, p.227-234

2009

Volltextzugriff (PDF)

Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution

Leukemia, 2015-01, Vol.29 (1), p.249-252

2015

Volltextzugriff (PDF)

Developmental changes in human megakaryopoiesis

Journal of thrombosis and haemostasis, 2013-09, Vol.11 (9), p.1730-1741

2013

Volltextzugriff (PDF)

The abnormal proplatelet formation in MYH9‐related macrothrombocytopenia results from an increased actomyosin contractility and is rescued by myosin IIA inhibition

Journal of thrombosis and haemostasis, 2013-12, Vol.11 (12), p.2163-2175

2013

Volltextzugriff (PDF)

STAT3 mutations identified in human hematologic neoplasms induce myeloid malignancies in a mouse bone marrow transplantation model

Haematologica (Roma), 2013-11, Vol.98 (11), p.1748-1752

2013

Volltextzugriff (PDF)

CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model

Cell death & disease, 2012-10, Vol.3 (10), p.e396-e396

2012

Volltextzugriff (PDF)

Transfer of differentiation signal by membrane microvesicles harboring hedgehog morphogens

Blood, 2006-11, Vol.108 (9), p.3012-3020

2006

Volltextzugriff (PDF)

Persistent STAT5 activation in myeloid neoplasms recruits p53 into gene regulation

Oncogene, 2015-03, Vol.34 (10), p.1323-1332

2015

Volltextzugriff (PDF)

Thrombocytopenia induced by the histone deacetylase inhibitor abexinostat involves p53-dependent and -independent mechanisms

Cell death & disease, 2013-07, Vol.4 (7), p.e738-e738

2013

Volltextzugriff (PDF)

Caspase-activated ROCK-1 allows erythroblast terminal maturation independently of cytokine-induced Rho signaling

Cell death and differentiation, 2011-04, Vol.18 (4), p.678-689

2011

Volltextzugriff (PDF)

Oncogenic mechanisms in myeloproliferative disorders

Cellular and molecular life sciences : CMLS, 2006-12, Vol.63 (24), p.2939-2953

2006

Volltextzugriff (PDF)

Primary hematopoietic cells from DBA patients with mutations in RPL11 and RPS19 genes exhibit distinct erythroid phenotype in vitro

Cell death & disease, 2012-07, Vol.3 (7), p.e356-e356

2012

Volltextzugriff (PDF)

1 – 25 von 426

Suche als RSS-Feed

Aktive Filter

ThemaCell Physiology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(393)
Mit Volltextzugriff
(337)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(254)
Science & Technology
(243)
Life Sciences & Biomedicine
(239)
Hematology
(161)
Biological And Medical Sciences
(118)
Animals
(110)
Mice
(92)
Medical Sciences
(83)
Cells, Cultured
(65)
Cell Line
(58)
Hematologic And Hematopoietic Diseases
(57)
Female
(54)
Cell Differentiation
(53)
Oncology
(52)
Male
(47)
Adult
(46)
Cell Biology
(45)
Mutation
(45)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(39)
Fundamental And Applied Biological Sciences. Psychology
(37)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(123)
Leukemia
(49)
British Journal Of Haematology
(16)
Experimental Hematology
(16)
Oncogene
(10)
Journal Of Thrombosis And Haemostasis
(9)
Leukemia Research
(9)
Blood Cells
(8)
Haematologica
(8)
Hematology And Cell Therapy
(6)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

JAK/STAT signaling in hematological malignancies

The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases

MPL/JAK2: from one signaling pathway to several disorders

JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma

Thrombopoietin receptor is required for the oncogenic function of CALR mutants

Mutations of ASXL1 gene in myeloproliferative neoplasms

Pathologic activation of thrombopoietin receptor and JAK2-STAT5 pathway by frameshift mutants of mouse calreticulin

A role for reactive oxygen species in JAK2 V617F myeloproliferative neoplasm progression

JAK2 negatively regulates p53 stabilization by enhancing MDM2 via La expression in myeloproliferative neoplasms

From hematopoietic stem cells to platelets

Myelofibrosis, JAK2 inhibitors and erythropoiesis

The cell division control protein 42–Src family kinase–neural Wiskott–Aldrich syndrome protein pathway regulates human proplatelet formation

TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis

Regulation of megakaryocyte maturation and platelet formation

Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution

Developmental changes in human megakaryopoiesis

The abnormal proplatelet formation in MYH9‐related macrothrombocytopenia results from an increased actomyosin contractility and is rescued by myosin IIA inhibition

STAT3 mutations identified in human hematologic neoplasms induce myeloid malignancies in a mouse bone marrow transplantation model

CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model

Transfer of differentiation signal by membrane microvesicles harboring hedgehog morphogens

Persistent STAT5 activation in myeloid neoplasms recruits p53 into gene regulation

Thrombocytopenia induced by the histone deacetylase inhibitor abexinostat involves p53-dependent and -independent mechanisms

Caspase-activated ROCK-1 allows erythroblast terminal maturation independently of cytokine-induced Rho signaling

Oncogenic mechanisms in myeloproliferative disorders

Primary hematopoietic cells from DBA patients with mutations in RPL11 and RPS19 genes exhibit distinct erythroid phenotype in vitro

Aktive Filter

Suchergebnisse filtern